Prashant Sakharkar

Dr. Prashant Sakharkar


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2015 in Research in Social and Administrative Pharmacy
Verified
Journal Article
Closed access
PSPrashant Sakharkar
Prashant Sakharkar
MBMark Bounthavong
Mark Bounthavong
JHJan D. Hirsch
Jan D. Hirsch
Candis M. MorelloCandis M. Morello
Candis M. Morello
TCTimothy C. Chen
Timothy C. Chen
ALAnandi V Law
Anandi V Law

3 June 2018 in International Journal of Hepatology
Verified
Journal Article
Open access
PDF file
Subrata DebSubrata Deb
Subrata Deb
PPPrasanth Puthanveetil
Prasanth Puthanveetil
PSPrashant Sakharkar
Prashant Sakharkar
Background. To examine the association between low-density lipoprotein (LDL) and high-density lipoprotein (HDL) levels and liver enzyme functions. Methods. The National Health and Nutrition Examination Survey (NHANES) data from 1999 to 2012 was used to examine the association between liver enzymes and lipid levels amongst adults in the United States. Results. Sixteen percent adults had ALT > 40 U/L, 11% had AST > 40 U/L, and 96% had ALP > 120 U/L. Age, gender, and race/ethnicity showed significant association with LDL, HDL, and triglycerides levels. LDL greater than borderline high was associated with little over two times higher odds of elevated ALT (OR: 2.33, 95% CI: 2.17, 2.53, p≤0.001) and AST (OR: 2.79, 95% CI: 2.55, 3.06, p≤0.001). High HDL was associated with 50% higher odds for elevated ALT (OR: 1.51, 95% CI: 1.39, 1.64, p≤0.001) and over two-and-half fold elevated AST (OR: 2.77, 95% CI: 2.47, 3.11, p≤0.001). LDL-C, HDL-C, and triglycerides were found to be good predictor of elevated ALT, AST, and ALP levels. Similarly, old age and female gender were significant predictor of elevated ALT and AST (p≤0.001). Conclusions. Underlying hepatic pathophysiology from dyslipidemia deserves further exploration due to its potential effects on hepatic drug metabolism/detoxification.

17 September 2021 in Diseases
Verified
Journal Article
Open access
PDF file
Subrata DebSubrata Deb
Subrata Deb
PSPrashant Sakharkar
Prashant Sakharkar
To examine the association between uric acid levels and liver enzyme functions amongst adults with hyperuricemia and gout in the United States. The National Health and Nutrition Examination Survey (NHANES) data from 2007 to 2016 was used to study the research objective. Data were analyzed for descriptive statistics and for differences using the t test, Chi-square test and ANOVA. A regression analysis was performed to determine association between demographics and liver enzymes. A p value of <0.05 or <0.001 was considered statistically significant. A total of 14,946 adults (≥20 yrs.) were included in this study. Sample mean age was 49 ± 0.15 yrs., and 54% were female. Overall, 15% adults had elevated uric acid levels (≥6.8 mg/dL), men had significantly higher uric acid levels than women (6 mg/dL vs. 4.8 mg/dL). High uric acid levels were associated with more than two times higher odds of elevated ALT, AST and GGT (p < 0.001). Similarly, gender-based target uric acid values were associated with two-fold increased odds of GGT, over one-and-a-half fold higher odds of ALT and AST (p < 0.001). Regression analysis showed significant association between age, gender, race/ethnicity, body mass index, and hypertension and ALT, AST, ALP, total bilirubin and GGT (p < 0.001). Adults with hyperuricemia and gout are most likely to develop liver dysfunctions and suffer associated morbidities. Such patients need to be appropriately monitored and managed for their liver functions and to prevent associated morbidities.

1 January 2017 in Journal of Basic and Clinical Pharmacy
Verified
Journal Article
Open access
PDF file
PSPrashant Sakharkar
Prashant Sakharkar
J Basic Clin Pharma, Official publication of Global Scientific Research Forum,Saudi Arabia

17 October 2012 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
DVDon Vu
Don Vu
PSPrashant Sakharkar
Prashant Sakharkar
ETEglis Tellez-Corrales
Eglis Tellez-Corrales
TSTariq Shah
Tariq Shah
IHIan Hutchinson
Ian Hutchinson
DMDavid I. Min
David I. Min

9 October 2022 in Diseases
Verified
Journal Article
Open access
PDF file
PSPrashant Sakharkar
Prashant Sakharkar
KFKafi Friday
Kafi Friday
Background: Health disparities and mental health issues have not been fully explored among sexual minorities. This study aims to examine health disparities and severity of depression among sexual minorities using a nationally representative sample of the US population. Methods: The National Health and Nutrition Examination Survey (NHANES) data from 2011 to 2016 were analyzed. The Patient Health Questionnaire (PHQ-9) was used to examine the severity of depression among sexual minorities compared to heterosexuals. Data were analyzed for descriptive statistics and associations using the Chi-squared test. A multivariate logistic regression analysis was used to quantify the magnitude of association between severity of depression and demographic characteristics. A p-value of <0.05 was considered statistically significant. Results: Among 7826 participants included, 426 (5.4%) were identified as a sexual minority. Moderately severe to severe depression was observed among 9.3% of sexual minorities with women having higher rates (64.2%) than men. Similarly, sexual minorities were two times more likely to have moderately severe to severe depression, two and half times more likely to see a mental health professional, and one and half times more likely to have genital herpes and be a user of illicit drugs than heterosexuals. In addition, they were less likely to be married and more likely to have been born in the United States, be a U.S. citizen, and earn less than USD 25,000 (p < 0.05). Conclusions: Sexual minorities are affected by a range of social, structural, and behavioral issues impacting their health. The screening of individuals with depression who are sexual minorities (especially females), illicit drug users, poor, or aged over 39 years may benefit from early intervention efforts.